Australia’s Therapeutic Goods Administration (TGA) has reinforced compliance expectations for sunscreen labelling, with a renewed focus on ensuring that approved indications, SPF claims, and broad-spectrum representations precisely match ARTG registrations and validated performance data. In Australia, primary sunscreens are regulated as therapeutic goods, not ordinary cosmetics, reflecting the country’s high UV exposure and strong public health orientation toward skin cancer prevention. The TGA has identified cases where marketed claims exceeded approved indications or where performance communication risked misleading consumers, prompting closer oversight. This enforcement climate coincides with broader international discussions around sunscreen ingredient safety, including scrutiny of certain organic UV filters, concerns about systemic absorption data, environmental persistence of some filters, and evolving toxicological evaluations in the EU and U.S. While Australia continues to permit a range of approved UV filters under its therapeutic framework, sponsors must ensure rigorous alignment between safety dossiers, stability data, efficacy testing, and on-pack claims. For industry, the message is clear: compliance in Australia requires both robust scientific substantiation of UV filter safety and precise regulatory communication, as authorities maintain one of the most stringent sunscreen oversight regimes globally.